10122-141 : Retavase Kit
NDC: | 10122-141 |
Labeler: | Chiesi USA, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Kit |
Application #: | BLA103786 |
Rev. Date: |
NDC Package Codes:
- 10122-141-02: 1 KIT IN 1 BOX (10122‑141‑02) * 10 ML IN 1 VIAL, SINGLE‑USE * 10 ML IN 1 SYRINGE
Active Ingredients:
- Reteplase
Related Products:
Based on records with the same trade name.- 10122-143 Retavase Kit by Chiesi USA, Inc.
- 24477-040 Retavase Kit by Ekr Therapeutics, Inc.
- 24477-041 Retavase Kit by Ekr Therapeutics, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 10122-104Next: 10122-143 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.